These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27060343)

  • 1. Modifications to bicarbonate conductivity: A way to increase phosphate removal during hemodialysis? Proof of concept.
    Bertocchio JP; Mohajer M; Gaha K; Ramont L; Maheut H; Rieu P
    Hemodial Int; 2016 Oct; 20(4):601-609. PubMed ID: 27060343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive Hemodialysis, Mineral and Bone Disorder, and Phosphate Binder Use.
    Copland M; Komenda P; Weinhandl ED; McCullough PA; Morfin JA
    Am J Kidney Dis; 2016 Nov; 68(5S1):S24-S32. PubMed ID: 27772640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of using two dialyzers in parallel on phosphate clearance in hemodialysis patients: a randomized trial.
    Thompson S; Manns B; Lloyd A; Hemmelgarn B; MacRae J; Klarenbach S; Unsworth L; Courtney M; Tonelli M
    Nephrol Dial Transplant; 2017 May; 32(5):855-861. PubMed ID: 27190374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does concomitant administration of sevelamer and calcium carbonate modify the control of phosphatemia?
    Ouellet G; Cardinal H; Mailhot M; Ste-Marie LG; Roy L
    Ther Apher Dial; 2010 Apr; 14(2):172-7. PubMed ID: 20438539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The influence of short-term magnesium carbonate treatment on calcium-phosphorus balance in dialysis patients].
    Zwiech R; Dryja P; Łacina D; Króliczak V; Chrul S; Kacprzyk F
    Wiad Lek; 2011; 64(1):9-14. PubMed ID: 21812357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphate removal during hemodialysis, hemodiafiltration, and hemofiltration. A reappraisal.
    Man NK; Chauveau P; Kuno T; Poignet JL; Yanai M
    ASAIO Trans; 1991; 37(3):M463-5. PubMed ID: 1751238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphate mass removal during hemodialysis: a comparison between eKT/V-matched conventional and extended dialysis.
    Sampaio MS; Ruzany F; Dorigo DM; Suassuna JH
    Am J Nephrol; 2012; 36(2):121-6. PubMed ID: 22776782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of varying dialysate bicarbonate concentration on serum phosphate.
    Kobrin SM; Raja RM
    ASAIO Trans; 1989; 35(3):423-5. PubMed ID: 2597494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild hyperphosphatemia and mortality in hemodialysis patients.
    Rodriguez-Benot A; Martin-Malo A; Alvarez-Lara MA; Rodriguez M; Aljama P
    Am J Kidney Dis; 2005 Jul; 46(1):68-77. PubMed ID: 15983959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphate removal model: an observational study of low-flux dialyzers in conventional hemodialysis therapy.
    Wang M; Li H; Liao H; Yu Y; You L; Zhu J; Huang B; Yuan L; Hao C; Chen J
    Hemodial Int; 2012 Jul; 16(3):363-76. PubMed ID: 22360645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
    Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP
    Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of gastric secretion by omeprazole and efficiency of calcium carbonate on the control of hyperphosphatemia in patients on chronic hemodialysis.
    Hardy P; Sechet A; Hottelart C; Oprisiu R; Abighanem O; Said S; Rasombololona M; Brazier M; Moriniere P; Achard JM; Pruna A; Fournier A
    Artif Organs; 1998 Jul; 22(7):569-73. PubMed ID: 9684693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of oral sodium bicarbonate supplementation in maintaining acid-base balance and its influence on the cardiovascular system in chronic hemodialysis patients - results of a prospective study.
    Voiculeț C; Zară O; Bogeanu C; Văcăroiu I; Aron G
    J Med Life; 2016; 9(4):449-454. PubMed ID: 27928454
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of gastric acid suppression with pantoprazole on the efficacy of calcium carbonate as a phosphate binder in haemodialysis patients.
    Cervelli MJ; Shaman A; Meade A; Carroll R; McDonald SP
    Nephrology (Carlton); 2012 Jul; 17(5):458-65. PubMed ID: 22471559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidisciplinary education approach to optimize phosphate control among hemodialysis patients.
    Chan MW; Cheah HM; Mohd Padzil MB
    Int J Clin Pharm; 2019 Oct; 41(5):1282-1289. PubMed ID: 31302884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphate removal with several thrice-weekly dialysis methods in overweight hemodialysis patients.
    Tonelli M; Wang W; Hemmelgarn B; Lloyd A; Manns B;
    Am J Kidney Dis; 2009 Dec; 54(6):1108-15. PubMed ID: 19619920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensified treatment of hyperphosphatemia associated with reduction in parathyroid hormone in patients on maintenance hemodialysis.
    Chen L; He JX; Chen YY; Ling YS; Lin CH; Guan TJ
    Ren Fail; 2018 Nov; 40(1):15-21. PubMed ID: 29295646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correcting acidosis in hemodialysis: effect on phosphate clearance and calcification risk.
    Harris DC; Yuill E; Chesher DW
    J Am Soc Nephrol; 1995 Dec; 6(6):1607-12. PubMed ID: 8749687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of daily dialysis in the control of hyperphosphatemia.
    Achinger SG; Ayus JC
    Kidney Int Suppl; 2005 Jun; (95):S28-32. PubMed ID: 15882310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.